Curocell Inc
372320
Company Profile
Business description
Curocell Inc is engaged in medical and pharmaceutical research and development. The company is into development of CAR-T treatments that enhance the natural function of immune cells to eliminate cancer cells through genetic manipulation of human immune cells.
Contact
11, Gukjegwahak 16-ro
Yuseong-gu
Daejeon34002
KORT: +82 428633698
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
109
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 7,704.40 | 180.10 | 2.39% |
| CAC 40 | 7,166.52 | 239.40 | 3.46% |
| DAX 40 | 20,370.40 | 580.78 | 2.93% |
| Dow JONES (US) | 37,965.60 | 2,580.33 | -6.36% |
| FTSE 100 | 7,966.43 | 264.35 | 3.43% |
| HKSE | 20,127.68 | 299.38 | 1.51% |
| NASDAQ | 15,603.26 | 947.34 | -5.72% |
| Nikkei 225 | 33,012.58 | 1,876.00 | 6.03% |
| NZX 50 Index | 11,891.44 | 115.56 | 0.98% |
| S&P 500 | 5,062.25 | 0.00 | 0.00% |
| S&P/ASX 200 | 7,510.00 | 166.70 | 2.27% |
| SSE Composite Index | 3,145.55 | 48.97 | 1.58% |